Erectile dysfunction (ED) also known as impotence, refers to problems with achieving and maintaining erections.Currently available treatment for erectile dysfunction is oral therapy, usually with pde-5 inhibitors (sildenafil, tadalafil, avanafil and vardenafil), as well as penis implants, vacuum contractile devices and shockwave therapy.
This report contains market size and forecasts of Erectile Dysfunction Treatment in Global, including the following market information:
Global Erectile Dysfunction Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Erectile Dysfunction Treatment market was valued at 4995.6 million in 2021 and is projected to reach US$ 7328.5 million by 2028, at a CAGR of 5.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Erectile Dysfunction Treatment include Boston Scientific, Coloplast Group, Zephyr Surgical Implants, Medispec, Augusta Medical Systems, Eli Lilly, Pfizer, Bayer and BaiYunShan General Factory, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Erectile Dysfunction Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Erectile Dysfunction Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Erectile Dysfunction Treatment Market Segment Percentages, by Type, 2021 (%)
Oral Treatment
Penis Implant
Vacuum Shrinkage Device
Shock Wave Therapy
Global Erectile Dysfunction Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Erectile Dysfunction Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Specialist Clinic
Other
Global Erectile Dysfunction Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Erectile Dysfunction Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Erectile Dysfunction Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Erectile Dysfunction Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boston Scientific
Coloplast Group
Zephyr Surgical Implants
Medispec
Augusta Medical Systems
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
KARL STORZ
Dong-A ST
Metuchen Pharma
Seoul Pharma